Dr. Cooper-DeHoff is Associate Professor in the Department of Pharmacotherapy and Translational Research, College of Pharmacy and Division of Cardiovascular Medicine, College of Medicine, and Associate Director of the Center for Pharmacogenomics at the University of Florida in Gainesville, Florida. She earned her Pharm D degree from the University of California at San Francisco, School of Pharmacy in 1986 and completed a clinical residency there in 1987. Subsequently, in 2007, she graduated from the University of Florida with a master’s degree in medical sciences, with an emphasis in clinical and translational research. Dr. Cooper-DeHoff’s research interests include hypertension, metabolic syndrome and diabetes, coronary artery disease and pharmacogenetics and most recently, precision medicine. She is an M-PI on the NIH funded grant entitled Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) and previously held an NIH-funded Career Development Award (K23) entitled “Metabolic Effects of Antihypertensive Drugs” and was co-investigator on an NIH funded pharmacogenetics grant. She was also an investigator of the International Verapamil Trandolapril Study (INVEST) which evaluated hypertension treatments in elderly coronary artery disease patients. She is also a member of the UF IRB and serves as a resource on human subjects research and ethics for the College of Pharmacy.